[正版] Fishman肺部疾病英文第5版 彩色插图呼吸系统肺结核肺部感染鉴别案例分析实用重症医学书籍

        店铺公告

  为保障消费者合理购买需求及公平交易机会，避免因非生活消费目的的购买货囤积商品，抬价转售等违法行为发生，店铺有权对异常订单不发货且不进行赔付。异常订单：包括但不限于相同用户ID批量下单，同一用户（指不同用户ID，存在相同/临近/虚构收货地址，或相同联系号码，收件人，同账户付款人等情形的）批量下单（一次性大于5本），以及其他非消费目的的交易订单。

温馨提示：请务必当着快递员面开箱验货，如发现破损，请立即拍照拒收，如验货有问题请及时联系在线客服处理，（如开箱验货时发现破损，所产生运费由我司承担，一经签收即为货物完好，如果您未开箱验货，一切损失就需要由买家承担，所以请买家一定要仔细验货）。

  关于退货运费：对于下单后且物流已发货货品在途的状态下，原则上均不接受退货申请，如顾客原因退货需要承担来回运费，如因产品质量问题（非破损问题）可在签收后，联系在线客服。

 

 

著  者：（美）Michael A.Grippi 等   

字 数：5000千

书  号：9787550293649 

页 数：2576 

出  版：北京联合出版公司  

印 张：161

尺  寸：216毫米×276毫米

开 本：1/16                   

装 帧：精装               

定 价：1298.00元

 

 

 

Michael A.Grippi教授是美国宾夕法尼亚大学医学院副教授，Good Shepherd Penn Partners Specialty Hospital的首席医疗官。Michael A.Grippi教授是世界的呼吸科专家，担任本书第3版、第4版、第5版的主编。

 

Contributors

Preface

Volume 1

Part 1: Perspectives

Milestones in the History of Pulmonary medicine  

Part 2: Scientific Basis of lung Function in Health and Disease

Section  1     Genetic, Cellular, and Structural Basis of Normal  Lung  Function

2     Functional Design of the Human lung for Gas exchange    

3     The respiratory muscles 

4     Molecular regulation of lung Development

5     Pulmonary Surfactant and Disorders ofSurfactant Homeostasis  

6     Mucociliary Clearance  

7  The Genetic Basis of respiratory Disorders

8     Stem Cells and respiratory Disease:Prospects for the Future      

9     Personalized Pulmonary medicine

Section  2     Physiological  Principles  of Normal Lung Function

10    Pulmonary mechanics   

11    Control of Ventilation   

12    Circadian rhythms and Sleep Biology  

13    Pulmonary Circulation  

14    Ventilation, Pulmonary Blood Flow, and Ventilation–Perfusion relationships

15    Blood-Gas transport

16    Diffusion, Chemical reactions, and Diffusing Capacity

17    Acid–Base Balance

Section  3     The Lungs in Different Physiological States

18    Respiratory System response to exercise in Health      

19    Aging of the respiratory System

Section  4     Lung  Immunology

20    Innate and adaptive immunity in the lung    

21    Lymphocyte- and macrophage-mediated inflammation in the lung    

22    Mast Cells and eosinophils

23   Leukocyte accumulation in Pulmonary Disease   

24    Antibody-mediated lung Defenses and Humoral immunodeficiency  

Section  5     Lung  Injury  and   Repair

25    Tlymphocytes in the lung     

26    Chemokines, adipokines, and Growth Factors in the lung   

27  Redox Signaling and oxidative Stress in lung Diseases

28    Fibroblasts in lung Homeostasis and Disease

Part 3: Symptoms and Signs of respiratory Disease

Section  6       Clinical  Approach  to  the  Patient

29    Approach to the Patient with respiratory Symptoms   

 Section  7         Diagnostic  Procedures

30    Modern approach to thoracic imaging Diagnosis       

31    Thoracic ultrasonography      

32    Physiologic and metabolic Study of Pulmonary Disorders using Conventional imaging

techniques and Positron emission tomography      

33    Pulmonary  Function testing      

34    Principles and applications of Cardiopulmonary exercise  testing

35    Diagnostic  Bronchoscopy,  transthoracic needle Biopsy, and related Procedures  

36    Interventional  Bronchoscopy    

37    Diagnostic thoracic Surgical Procedures:thoracoscopy, VatS, and thoracotomy

38    Evaluation of respiratory impairment and Disability

Part 4: Obstructive Lung Diseases

Section  8     Chronic   Obstructive   Pulmonary   Disease

39    Pathology of Chronic obstructive Pulmonary Disease: Diagnostic Features and Differential Diagnosis

40    Chronic obstructive Pulmonary Disease: epidemiology,Pathophysiology,  Pathogenesis,  andα1-antitrypsin Deficiency   

41    Cigarette Smoking and Smoking Cessation  

42    Course and treatment of Chronic obstructive Pulmonary Disease

43    Rehabilitation in Chronic obstructive Pulmonary Disease and other respiratory Disorders

Section  9     Asthma

44    The Biology of asthma  

45    Asthma: epidemiology  

46    Asthma: Clinical Presentation and management

47    Aspirin- and exercise-induced asthma

48    Allergic Bronchopulmonary aspergillosis (mycosis)

and Severe asthma with Fungal Sensitivity  

Section  10    Other   Obstructive   Disorders

49    Upper airway obstruction in adults     

50    Cystic Fibrosis       

51    Bronchiolitis  

52    Bullous Disease of the lung    

53    Bronchiectasis      

Part 5: interstitial and inflammatory lung Diseases

Section  11    Immunologic   and   Interstitial   Diseases

54    Interstitial lung Disease: a Clinical

overview and General approach   

55    Systemic Sarcoidosis

56    Idiopathic Pulmonary Fibrosis     

57    Idiopathic interstitial Pneumonias other than idiopathic Pulmonary Fibrosis     

58    Hypersensitivity Pneumonitis

59    Radiation Pneumonitis  

60    Pulmonary manifestations of the Collagen Vascular Diseases

61    Pulmonary langerhans’ Cell Histiocytosis    

62    Pulmonary lymphangioleiomyomatosis

63    Benign metastasizing leiomyoma

64    Depositional Diseases of the lungs

Part 6: Drug-induced lung Diseases

65    Pulmonary toxicity related to Chemotherapeutic agents     

66    Drug-induced Pulmonary Disease Due to nonchemotherapeutic agents

Part 7: Other infiltrative and airspace Disorders

67    The lungs in Patients with inborn errors of metabolism

68    Alveolar  Hemorrhage  Syndromes

69    Aspiration-related Pulmonary Disorders

70    Pulmonary alveolar Proteinosis Syndrome

71    The eosinophilic Pneumonias

Part 8: Disorders of the Pulmonary Circulation

72    Pulmonary  arterial  Hypertension

73    Pulmonary  thromboembolic  Disease

74    Pulmonary Vasculitis

75    Pulmonary  arteriovenous  malformations

Volume 2

Part 9: Disorders of the Pleural Space

76    Nonmalignant Pleural effusions

77    Malignant Pleural effusions

78    Pneumothorax

Part 10: Diseases of the mediastinum

79    Malignant mesothelioma and other Primary Pleural tumors

80    nonneoplastic Disorders of the mediastinum

81    Congenital Cysts of the mediastinum:Bronchopulmonary Foregut anomalies

82    Benign and malignant neoplasms of the mediastinum

Part 11: Disorders of the Chest Wall, Diaphragm, and Spine

83    nonmuscular Diseases of the Chest Wall

84    Effects of neuromuscular Diseases on Ventilation

85    Management of neuromuscular respiratory muscle Dysfunction

Part 12: Occupational and environmental  Disorders

Section  12    Occupational     Disorders

86    Asbestos-related lung Disease      

87    Chronic Beryllium Disease and Hard-metal lung Diseases

88    Coal Workers’ lung Diseases and Silicosis

89    Occupational asthma, Byssinosis, and industrial Bronchitis 

90    Acute and Chronic responses to toxic inhalations

Section  13    Environmental       Disorders

91    Indoor and outdoor air Pollution

92    High-altitude Physiology and Clinical Disorders

93    Diving injuries and air embolism 

94    Thermal lung injury and acute Smoke inhalation

Part 13: Pulmonary Complications of nonpulmonary Disorders

95    Noninfectious Pulmonary Complications of Hematopoietic Stem Cell and Solid organ transplantation   

96    Pulmonary Complications of Sickle Cell Disease

97    Pulmonary Disorders and Pregnancy   

98    Pulmonary Complications of intra-abdominal Disease

Part 14: Sleep and Sleep Disorders

99    Sleep apnea Syndromes: Central and obstructive

100  Sleep-related Hypoventilation Syndromes   

 101       Changes in the Cardiorespiratory System During Sleep

102  Differential Diagnosis and evaluation of Sleepiness

Part 15: Surgical aspects of Pulmonary medicine

103  Perioperative respiratory Considerations in the Surgical Patient 

104  Acute respiratory Failure in the Surgical Patient 

105  Perioperative Care of the Patient undergoing lung resection 106   thoracic trauma

107   Lung transplantation

Part 16: Neoplasms of the Lungs

Section  14    Lung   Cancer

108  Genetic and molecular Changes in lung Cancer: Prospects for a Personalized

Pharmacological approach to treatment

109  Epidemiology of lung Cancer

110  Approach to the Patient with Pulmonary nodule

111  The Pathology of Bronchogenic Carcinoma

112  Clinical evaluation, Diagnosis, and Lydia Chang / M. Patricia Rivera

113  Treatment of non–Small-Cell lung Cancer: Surgery

114  Treatment of non–Small-Cell lung Cancer: Chemotherapy

115  Treatment of non–Small-Cell

116  Small Cell lung Cancer: Diagnosis, treatment, and natural History

117  Primary lung tumors other than Bronchogenic Carcinoma: Benign and malignant

118  Extrapulmonary  Syndromes associated with lung tumors

 119 Pulmonary metastases: the role of Surgical reSection 

Section  15    Lymphoproliferative Disorders

120  Lymphoproliferative and Hematologic Diseases involving the lung and Pleura

Part 17:Infectious Diseases of the lungs

Section  16    General     Concepts

121  Pulmonary Clearance of infectious agents

122  Approach to the Patient with Pulmonary infection

123  Pulmonary infection in immunocompromised Hosts

124  Microbial Virulence Factors in Pulmonary infections

125  Principles of antibiotic use and the Selection of empiric therapy for Pneumonia

Section  17    Common  Syndromes  in  Pulmonary Infectious  Diseases

126  Infections of the upper respiratory tract

127  Aspiration, empyema, lung abscesses, and anaerobic infections

128  Acute Bronchitis and Community-acquired Pneumonia

129  Healthcare-acquired   Pneumonia, including Ventilator-associated Pneumonia

Section  18    Major Pathogens in Pulmonary Infections

130  Viral infections of the lung and respiratory tract

131   Tuberculosis

132  Diseases due to nontuberculous mycobacteria

133  Aspergillus, Candida, and other opportunistic mold infections of the lung

134  Cryptococcosis and the endemic mycoses

135   Pneumocystis Pneumonia

136   Protozoan infections of the thorax

137 Helminthic Diseases of the Lungs

138 Zoonotic and Other Unusual

Part 18: Acute respiratory Failure

139  Respiratory Failure: an overview

Section  19    Lung    Failure

140  Acute respiratory Distress Syndrome: Pathogenesis

141  Acute lung injury and the acute respiratory Distress Syndrome: Clinical Features, management, and outcomes

142  Sepsis, multiple organ Dysfunction Syndrome, and Chronic Critical illness

Section  20    Respiratory    Pump    Failure

143  Pump Failure: the Pathogenesis of Hypercapnic respiratory Failure in Patients

with lung and Chest Wall Disease

Section  21    Management   and   Therapeutic Interventions

144  Oxygen therapy and toxicity

147  Hemodynamic and respiratory monitoring in acute respiratory Failure

148  Principles of mechanical Ventilation

149 Nutrition in Pulmonary Disease

150  Diagnosis and treatment of Pain, agitation, and Delirium in the intensive Care unit

151  Early mobilization of Patients in the ICU

152  Organization of intensive Care units and long-term acute Care Hospitals

153  Ethics and Palliative Care in Critical Care units

APPENDIXES

Appendix A   Terms and Symbols in respiratory Physiology

Appendix B   Normal Values for a Healthy 20-Year old Seated man

Index  

目 录

  

Contributors

Preface

Volume 1

Part 1: Perspectives

1. Milestones in the History of Pulmonary medicine  

Part 2: Scientific Basis of lung Function in Health and Disease

Section  1     Genetic, Cellular, and Structural Basis of Normal  Lung  Function

2     Functional Design of the Human lung for Gas exchange    

3     The respiratory muscles 

4     Molecular regulation of lung Development

5     Pulmonary Surfactant and Disorders ofSurfactant Homeostasis  

6     Mucociliary Clearance  

7  The Genetic Basis of respiratory Disorders

8     Stem Cells and respiratory Disease:Prospects for the Future      

9     Personalized Pulmonary medicine

Section  2     Physiological  Principles  of Normal Lung Function

10    Pulmonary mechanics   

11    Control of Ventilation   

12    Circadian rhythms and Sleep Biology  

13    Pulmonary Circulation  

14    Ventilation, Pulmonary Blood Flow, and Ventilation–Perfusion relationships

15    Blood-Gas transport

16    Diffusion, Chemical reactions, and Diffusing Capacity

17    Acid–Base Balance

Section  3     The Lungs in Different Physiological States

18    Respiratory System response to exercise in Health      

19    Aging of the respiratory System

Section  4     Lung  Immunology

20    Innate and adaptive immunity in the lung    

21    Lymphocyte- and macrophage-mediated inflammation in the lung    

22    Mast Cells and eosinophils

23   Leukocyte accumulation in Pulmonary Disease   

24    Antibody-mediated lung Defenses and Humoral immunodeficiency  

Section  5     Lung  Injury  and   Repair

25    Tlymphocytes in the lung     

26    Chemokines, adipokines, and Growth Factors in the lung   

27  Redox Signaling and oxidative Stress in lung Diseases

28    Fibroblasts in lung Homeostasis and Disease

Part 3: Symptoms and Signs of respiratory Disease

Section  6       Clinical  Approach  to  the  Patient

29    Approach to the Patient with respiratory Symptoms   

 Section  7         Diagnostic  Procedures

30    Modern approach to thoracic imaging Diagnosis       

31    Thoracic ultrasonography      

32    Physiologic and metabolic Study of Pulmonary Disorders using Conventional imaging

techniques and Positron emission tomography      

33    Pulmonary  Function testing      

34    Principles and applications of Cardiopulmonary exercise  testing

35    Diagnostic  Bronchoscopy,  transthoracic needle Biopsy, and related Procedures  

36    Interventional  Bronchoscopy    

37    Diagnostic thoracic Surgical Procedures:thoracoscopy, VatS, and thoracotomy

38    Evaluation of respiratory impairment and Disability

Part 4: Obstructive Lung Diseases

Section  8     Chronic   Obstructive   Pulmonary   Disease

39    Pathology of Chronic obstructive Pulmonary Disease: Diagnostic Features and Differential Diagnosis

40    Chronic obstructive Pulmonary Disease: epidemiology,Pathophysiology,  Pathogenesis,  andα1-antitrypsin Deficiency   

41    Cigarette Smoking and Smoking Cessation  

42    Course and treatment of Chronic obstructive Pulmonary Disease

43    Rehabilitation in Chronic obstructive Pulmonary Disease and other respiratory 

 本书阐述了呼吸系统生物学、细胞学及分子机制、正常和疾病状态下的肺功能及相应的改变，并全面、详细介绍了多种呼吸系统疾病及其影响因素，其中包括阻塞性肺疾病和限制性肺疾病、肺血管病、睡眠呼吸障碍、肺部肿瘤、呼吸道感染、呼吸衰竭等。本书第5版对肺病医学的发展、干细胞和呼吸系统疾病、肺疾病遗传学与精准医疗等内容进行了更新。全书共500万余字，2000余幅图，60个视频，18000条参考文献。本书是呼吸科临床医生、实习生、肺部疾病研究人员必不可少的工具书。

 

经典著作 《Fishman肺部疾病》于1980年首次出版，整合了呼吸疾病、重症医学的基础知识和临床应用，是呼吸医学及相关基础和应用科学的奠基之作。
内容翔实 本书阐述了正常和疾病状态下肺功能及其改变，并全面、详细介绍了多种呼吸系统疾病及其影响因素，其中包括阻塞性和限制性肺疾病、肺血管病、睡眠呼吸障碍、肺部肿瘤、呼吸道感染、呼吸衰竭等。全书共500万余字，2000余幅图，60个视频，18000条参考文献。
全面更新 本书第5版对以下内容进行了全面更新，以反映其在过去几年取得的最新进展，包括：肺部分子医学的发展、干细胞和呼吸系统疾病、肺疾病遗传学与精准医疗、肺移植技术的进展、呼吸系统免疫学和免疫抑制的发展、肺高压的诊断和治疗、昼夜节律和睡眠生物学、肺部影像学包括功能显像的快速发展、现代介入支气管镜技术。同时涵盖了危重症医学领域的最新进展，包括早期诊断和治疗脓毒症、多器官功能障碍综合征（MODS）、急性呼吸窘迫综合征（ARDS）、重症监护室中躁动和谵妄的管理、“慢性危重病”的新定义等。

Michael A.Grippi教授是美国宾夕法尼亚大学医学院副教授，Good Shepherd Penn Partners Specialty Hospital的首席医疗官。Michael A.Grippi教授是世界知名的呼吸科专家，担任本书第3版、第4版、第5版的主编。�应的改变，并全面、详细介绍了多种呼吸系统疾病及其影响因素，其中包括阻塞性肺疾病和限制性肺疾病、肺血管病、睡眠呼吸障碍、肺部肿瘤、呼吸道感染、呼吸衰竭等。本书第5版对肺病医学的发展、干细胞和呼吸系统疾病、肺疾病遗传学与精准医疗等内容进行了更新。全书共500万余字，2000余幅图，60个视频，18000条参考文献。本书是呼吸科临床医生、实习生、肺部疾病研究人员必不可少的工具书。

1